While the simplicity of each of these model systems understates the complexity of HER2-overexpressing human breast cancers, it makes a compelling case that HER2 plays a dominant role in causing and maintaining the transformed phenotype, thus obligating these model systems to oncogenic stimulation. The gene discussed is ERBB2; the disease is breast cancer.